Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
25. November 2024 09:41 ET
|
ADvantage Therapeutics, Inc.
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Advantage Therapeutics Inc., a leader in developing therapies targeting age-related diseases, announced today the formation of its new subsidiary, Klothea...
ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan
09. September 2024 10:01 ET
|
ADvantage Therapeutics, Inc.
MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease,...
Discoverer of the Klotho Gene and Pioneer in Longevity and Disease Prevention Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics
05. Februar 2024 09:41 ET
|
Advantage Therapeutics Inc.
BOCA RATON, Fla. and VIENNA, Austria, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, a pioneer in developing therapies for neurodegenerative conditions by addressing the biology of aging,...
Guardian Capital Announces April 2023 Distributions for Guardian Capital ETFs
14. April 2023 07:00 ET
|
Guardian Capital LP
TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending April 30, 2023, in respect of the ETF series of the Guardian...
Renowned Public Health Advisor Jim O’Neill Joins Board of Directors of ADvantage Therapeutics
24. März 2023 08:45 ET
|
Advantage Therapeutics Inc.
BOCA RATON, Fla. and VIENNA, Austria, March 24, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), which is developing therapies to treat neurodegenerative...
Guardian Capital LP vise à révolutionner la retraite au moyen de solutions novatrices, y compris une tontine unique et moderne
07. September 2022 07:00 ET
|
Guardian Capital LP
Les solutions de longévité ParcoursGardéMC créées en partenariat avec le professeur Moshe A. Milevsky, PhD, sont conçues pour résoudre ce que l’économiste lauréat du prix Nobel William Sharpe a décrit...
Guardian Capital LP aims to revolutionize retirement with first-of-their-kind solutions, including a uniquely modern tontine
07. September 2022 07:00 ET
|
Guardian Capital LP
GuardPath™ Longevity Solutions, created in partnership with Professor Moshe A. Milevsky, PhD, are designed to address what Nobel Laureate Economist William Sharpe has described as the “nastiest,...
Florasophy Weighs Fiber as Medicine
07. April 2022 09:00 ET
|
Florasophy
Portland, Oregon, April 07, 2022 (GLOBE NEWSWIRE) -- PORTLAND, OR., April 7, 2022 — Florasophy, a collection of organic, clinician-developed soluble fiber blends, has launched in Portland, Oregon....
Guardian Capital Announces December 2020 Distributions for Guardian Capital ETFs
17. Dezember 2020 07:00 ET
|
Guardian Capital LP
TORONTO, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending December 31, 2020, in respect of the Guardian Capital ETFs...
Guardian Capital Announces Estimated Annual 2020 Special Distributions for Guardian Capital ETFs
04. Dezember 2020 18:00 ET
|
Guardian Capital LP
TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Guardian Capital LP ("Guardian Capital") announces the estimated annual special year-end distributions (the "Special Distributions") for the 2020 tax year...